Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

HAE

Haemonetics Corp.

May 15 • 04:00PM ET

96.49

Dollar change -0.88
Percentage change -0.90	%

Healthcare • Medical Instruments & Supplies • USA • NYSE

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: IJH VTI IWM VB VXF VBK IWO SCHA IJK VTWO

Scroll to Statements

Index	RUT	P/E	42.18	EPS (ttm)	2.29	Insider Own	0.98%	Shs Outstand	50.45M	Perf Week	3.47%
Market Cap	4.90B	Forward P/E	17.72	EPS next Y	5.44	Insider Trans	-0.46%	Shs Float	50.29M	Perf Month	14.64%
Income	117.56M	PEG	3.52	EPS next Q	1.00	Inst Own	98.20%	Short Float	5.22%	Perf Quarter	35.44%
Sales	1.31B	P/S	3.74	EPS this Y	16.06%	Inst Trans	-0.61%	Short Ratio	5.59	Perf Half Y	11.33%
Book/sh	18.57	P/B	5.19	EPS next Y	18.46%	ROA	5.69%	Short Interest	2.62M	Perf Year	8.22%
Cash/sh	3.52	P/C	27.41	EPS next 5Y	12.00%	ROE	13.22%	52W Range	70.74 - 97.75	Perf YTD	12.84%
Dividend Est.	2.00 (2.07%)	P/FCF	42.45	EPS past 5Y	17.09%	ROI	6.69%	52W High	-1.29%	Beta	0.40
Dividend TTM	-	Quick Ratio	1.50	Sales past 5Y	6.80%	Gross Margin	57.52%	52W Low	36.40%	ATR (14)	2.45
Dividend Ex-Date	-	Current Ratio	2.56	EPS Y/Y TTM	1.99%	Oper. Margin	14.33%	RSI (14)	69.58	Volatility	3.72% 2.97%
Employees	3034	Debt/Eq	0.84	Sales Y/Y TTM	12.01%	Profit Margin	8.98%	Recom	1.71	Target Price	110.17
Option/Short	Yes / Yes	LT Debt/Eq	0.83	EPS Q/Q	-30.93%	Payout	0.00%	Rel Volume	0.58	Prev Close	97.37
Sales Surprise	4.18%	EPS Surprise	0.92%	Sales Q/Q	12.77%	Earnings	May 09 BMO	Avg Volume	469.22K	Price	96.49
SMA20	6.48%	SMA50	13.41%	SMA200	13.44%	Trades		Volume	273,930	Change	-0.90%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-13-22	Initiated	Mizuho	Buy	$90
Jan-27-22	Downgrade	Needham	Buy → Hold
Dec-15-21	Downgrade	Citigroup	Buy → Neutral	$75 → $59
Aug-17-21	Resumed	Raymond James	Outperform	$75
Jun-17-21	Initiated	Citigroup	Buy	$75
May-14-21	Upgrade	CJS Securities	Market Perform → Market Outperform
Apr-20-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Apr-19-21	Downgrade	CJS Securities	Market Outperform → Market Perform
Feb-03-21	Upgrade	Barrington Research	Mkt Perform → Outperform	$140
Jan-21-21	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-05-20	Upgrade	Barrington Research	Mkt Perform → Outperform	$106
May-06-20	Downgrade	Barrington Research	Outperform → Mkt Perform
Mar-31-20	Upgrade	CJS Securities	Market Perform → Market Outperform
Jan-10-20	Initiated	Needham	Buy	$138
Aug-07-19	Reiterated	Barrington Research	Outperform	$116 → $139
May-14-19	Upgrade	Raymond James	Mkt Perform → Outperform	$110
May-08-19	Reiterated	Barrington Research	Outperform	$112 → $116
Aug-09-18	Reiterated	Barrington Research	Outperform	$90 → $118
Feb-07-18	Reiterated	Barrington Research	Outperform	$57 → $71
Jan-02-18	Upgrade	Morgan Stanley	Equal-Weight → Overweight

Show Previous Ratings

May-14-24 09:15AM	Haemonetics Corporation (HAE) Hit a 52 Week High, Can the Run Continue? (Zacks)
May-13-24 09:40AM	Why Haemonetics (HAE) is a Top Value Stock for the Long-Term (Zacks)
May-10-24 03:57PM	Haemonetics Corporation (NYSE:HAE) Q4 2024 Earnings Call Transcript (Insider Monkey)
12:41PM	Haemonetics Corp (HAE) Fiscal 2024 Earnings: Aligns with EPS Projections, Reveals Robust ... (GuruFocus.com)
10:53AM	Haemonetics (HAE) Q4 Earnings Top Estimates, Margins Expand (Zacks)
10:37AM	Loading…
10:37AM	Barrington Research Raises Price Target on Haemonetics to $107 From $105, Keeps Outperform Rating (MT Newswires)
May-09-24 10:55AM	HAE Stock Earnings: Haemonetics Beats EPS, Beats Revenue for Q4 2024 (InvestorPlace)
09:30AM	Haemonetics (HAE) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
07:20AM	Haemonetics (HAE) Q4 Earnings and Revenues Top Estimates (Zacks)
06:39AM	Haemonetics' Fiscal Q4 Adjusted Earnings, Revenue Rise (MT Newswires)
06:28AM	Haemonetics: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
06:00AM	Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website (PR Newswire)
May-08-24 09:15PM	Insider Sale at Haemonetics Corp (HAE): EVP, Chief Technology Officer Anila Lingamneni Sells ... (GuruFocus.com)
May-06-24 09:16AM	Exploring Analyst Estimates for Haemonetics (HAE) Q4 Earnings, Beyond Revenue and EPS (Zacks)
May-01-24 11:51AM	Haemonetics (HAE) Banks on Plasma Arm Growth Amid Rising Costs (Zacks)
09:03AM	Loading…
Apr-12-24 09:03AM	Why You Should Add Haemonetics (HAE) to Your Portfolio Now (Zacks)
Apr-10-24 04:58PM	Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024 (PR Newswire)
Apr-08-24 03:20PM	Royce Investment Partners Commentary: What Will Fuel Small-Cap Returns? (GuruFocus.com)
Apr-05-24 09:48AM	Haemonetics' (HAE) New TEG 6s Cartridge Gets FDA Approval (Zacks)
Apr-04-24 06:30AM	Haemonetics Receives FDA Clearance for New TEG 6s Global Hemostasis - HN Cartridge (PR Newswire)
Apr-01-24 08:00AM	Haemonetics Corporation Completes Acquisition of Attune Medical (PR Newswire)
Mar-29-24 09:30AM	Haemonetics (HAE) Crossed Above the 200-Day Moving Average: What That Means for Investors (Zacks)
Mar-11-24 09:30AM	Haemonetics (HAE) Recently Broke Out Above the 50-Day Moving Average (Zacks)
Mar-06-24 06:54AM	Haemonetics (HAE) Signs Agreement to Acquire Attune Medical (Zacks)
Mar-05-24 06:18AM	Haemonetics to buy Attune Medical for $160M (MedTech Dive)
06:00AM	Haemonetics Announces Definitive Agreement to Acquire Attune Medical (PR Newswire)
Feb-27-24 12:00PM	What Makes Haemonetics (HAE) a New Buy Stock (Zacks)
Feb-21-24 05:57PM	Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference (PR Newswire)
05:55PM	Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day (PR Newswire)
Feb-18-24 01:26PM	25 Most Valuable Medical Device Companies in the US (Insider Monkey)
10:39AM	Loading…
Feb-09-24 10:39AM	Haemonetics (HAE) Q3 Earnings Top Estimates, 2024 View Raised (Zacks) -5.01%
10:34AM	Haemonetics Corporation (NYSE:HAE) Q3 2024 Earnings Call Transcript (Insider Monkey)
09:40AM	Here's Why Haemonetics (HAE) is a Strong Value Stock (Zacks)
Feb-08-24 10:00PM	Q3 2024 Haemonetics Corp Earnings Call (Thomson Reuters StreetEvents)
09:30AM	Haemonetics (HAE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
07:10AM	Haemonetics (HAE) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
06:33AM	Haemonetics Corp (HAE) Reports Revenue Growth and Updates Fiscal 2024 Guidance (GuruFocus.com)
06:10AM	Haemonetics: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
06:00AM	Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website (PR Newswire)
Feb-05-24 09:16AM	Haemonetics (HAE) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
Feb-01-24 10:00AM	Haemonetics (HAE) Earnings Expected to Grow: Should You Buy? (Zacks)
Jan-31-24 12:45PM	Is Haemonetics (HAE) a Solid Growth Stock? 3 Reasons to Think 'Yes' (Zacks)
Jan-18-24 09:40AM	Why Haemonetics (HAE) is a Top Value Stock for the Long-Term (Zacks)
Jan-12-24 09:45AM	Here's Why Haemonetics (HAE) is a Strong Growth Stock (Zacks)
Jan-11-24 04:05PM	Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024 (PR Newswire)
Jan-03-24 01:56PM	Haemonetics (HAE) Up 11% in a Year: Will the Rally Continue? (Zacks)
Dec-29-23 12:34PM	Here's Why Haemonetics (HAE) is a Strong Value Stock (Zacks)
Dec-25-23 09:30AM	Haemonetics (HAE) Just Reclaimed the 200-Day Moving Average (Zacks)
09:30AM	Haemonetics (HAE) Just Overtook the 50-Day Moving Average (Zacks)
Dec-18-23 09:45AM	Why Haemonetics (HAE) is a Top Growth Stock for the Long-Term (Zacks)
Dec-15-23 12:45PM	Haemonetics (HAE) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
Dec-12-23 06:00AM	Haemonetics Corporation Completes Acquisition of OpSens Inc. (PR Newswire)
Dec-07-23 04:05PM	Haemonetics to Present at 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-05-23 09:40AM	Why Haemonetics (HAE) is a Top Value Stock for the Long-Term (Zacks)
Dec-04-23 12:09PM	Here's Why You Should Invest in Haemonetics (HAE) Right Now (Zacks)
Nov-30-23 09:35AM	Haemonetics (HAE) Loses -6.71% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Nov-28-23 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Haemonetics (HAE) (Zacks)
Nov-27-23 12:39PM	Haemonetics (HAE) Stock Up 4.2% YTD: Will the Rally Continue? (Zacks)
10:46AM	Haemonetics' (HAE) Plasma Growth, Innovation Aid Performance (Zacks)
Nov-23-23 09:45AM	Here's Why Haemonetics (HAE) is a Strong Growth Stock (Zacks)
Nov-10-23 12:45PM	Is Haemonetics (HAE) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
Nov-06-23 09:45AM	Why Haemonetics (HAE) is a Top Growth Stock for the Long-Term (Zacks)
Nov-05-23 02:30PM	Haemonetics Corporation (NYSE:HAE) Q2 2024 Earnings Call Transcript (Insider Monkey)
Nov-03-23 10:31AM	Haemonetics (HAE) Q2 Earnings Top Estimates, 2024 View Up (Zacks)
Nov-02-23 09:30AM	Compared to Estimates, Haemonetics (HAE) Q2 Earnings: A Look at Key Metrics (Zacks)
07:34AM	Haemonetics Corp (HAE) Reports 7% Revenue Increase in Q2 Fiscal 2024 (GuruFocus.com)
07:00AM	OPSENS RECEIVES INTERIM ORDER AND FILES MANAGEMENT INFORMATION CIRCULAR IN CONNECTION WITH SPECIAL MEETING OF SHAREHOLDERS (PR Newswire)
06:18AM	Haemonetics: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
06:00AM	Haemonetics 2nd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website (PR Newswire)
Nov-01-23 06:27PM	3 Medical Products Stocks to Consider as Earnings Approach (Zacks)
Oct-26-23 10:02AM	Haemonetics (HAE) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Oct-20-23 12:45PM	Haemonetics (HAE) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
09:40AM	Has Connect Biopharma Holdings (CNTB) Outpaced Other Medical Stocks This Year? (Zacks)
Oct-19-23 11:49AM	Here's Why You Should Invest in Haemonetics (HAE) Right Now (Zacks)
Oct-18-23 11:10AM	Quest Diagnostics (DGX) Gains From New Alliances Amid FX Woes (Zacks)
11:05AM	Align (ALGN) Gains From New Launches, Strategic Partnerships (Zacks)
Oct-17-23 11:17AM	STERIS' (STE) Improved Volume, New Buyouts Drive Growth (Zacks)
08:33AM	Orthofix (OFIX) Secures FDA 510k Clearance for OsteoCove Graft (Zacks)
Oct-16-23 08:28AM	Boston Scientific's (BSX) Wavewriter Alpha SCS Gets FDA's Nod (Zacks)
Oct-13-23 10:05AM	Globus Medical (GMED) Gains From NuVasive Buyout, Innovation (Zacks)
08:28AM	Labcorp (LH) Launches Biomarker Test for Alzheimer's Disease (Zacks)
Oct-12-23 12:04PM	Alcon (ALC) Gains From Growing Market Demand, New Launches (Zacks)
11:58AM	ZimVie (ZIMV) Progresses in Dental Space With Biotivity Launch (Zacks)
08:33AM	Hologic (HOLX) to Elevate OB-GYN Training With New Partnerships (Zacks)
08:14AM	5 Medical Product Stocks to Buy Amid Industry Recovery (Zacks)
Oct-11-23 12:00PM	Haemonetics (HAE) Moves to Strong Buy: Rationale Behind the Upgrade (Zacks)
11:13AM	Haemonetics (HAE) Announces Agreement to Acquire OpSens (Zacks)
08:23AM	Here's Why You Should Retain Exact Sciences (EXAS) Stock Now (Zacks)
Oct-10-23 06:00AM	OPSENS SIGNS DEFINITIVE AGREEMENT FOR ITS ACQUISITION BY HAEMONETICS (PR Newswire)
06:00AM	Haemonetics Corporation Announces Definitive Agreement to Acquire OpSens, Inc. (PR Newswire)
Oct-09-23 08:35AM	Here's Why You Should Retain Tandem Diabetes (TNDM) Now (Zacks)
Oct-06-23 07:48AM	Thermo Fisher (TMO) Expands Capabilities in St. Louis Facility (Zacks)
Oct-05-23 04:05PM	Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2024 Results: November 2, 2023 (PR Newswire)
11:16AM	Ken Fisher Portfolio: 15 Biggest Small-Cap Positions (Insider Monkey)
09:51AM	QIAGEN (QGEN) Broadens QuantiFERON Line With EBV RUO Assay (Zacks)
08:32AM	Bruker (BRKR) Becomes Majority Investor in MIRO Analytical AG (Zacks)
08:25AM	Here's Why Investors Should Retain Integra (IART) Stock Now (Zacks)
Oct-04-23 09:50AM	Penumbra (PEN) Rides on New Product Offerings as FX Woe Ails (Zacks)
09:40AM	Is Haemonetics (HAE) Stock Outpacing Its Medical Peers This Year? (Zacks)
08:47AM	Bruker (BRKR) Introduces the New Hysitron TI 990 TriboIndenter (Zacks)

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, Hospital, and Corporate. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lingamneni Anila	EVP, Chief Technology Officer	May 06 '24	Sale	95.00	2,305	218,975	12,295	May 08 04:21 PM
Strong Stewart W	President, Global Hospital	Sep 12 '23	Sale	90.65	228	20,668	16,221	Sep 13 04:19 PM
Lingamneni Anila	EVP, Chief Technology Officer	Sep 11 '23	Sale	90.00	2,305	207,450	14,495	Sep 13 04:20 PM
Dockendorff Charles J	Director	Sep 05 '23	Sale	87.68	10,215	895,651	2,226	Sep 07 04:23 PM
Llorens Josep	EVP, Global Manufacturing	Jul 18 '23	Option Exercise	57.10	4,928	281,390	23,391	Jul 20 04:17 PM
Llorens Josep	EVP, Global Manufacturing	Jul 18 '23	Sale	90.00	4,928	443,520	18,463	Jul 20 04:17 PM
Simon, Christopher	President & CEO	Jun 29 '23	Option Exercise	28.61	196,746	5,629,887	414,113	Jun 30 04:17 PM
Strong Stewart W	President, Global Hospital	Jun 07 '23	Option Exercise	56.93	6,893	392,419	24,040	Jun 09 04:16 PM
Strong Stewart W	President, Global Hospital	Jun 07 '23	Sale	88.04	2,538	223,446	16,449	Jun 09 04:16 PM
Lingamneni Anila	EVP, Chief Technology Officer	May 30 '23	Sale	83.33	2,304	191,992	16,800	Jun 01 04:19 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

HAE

Haemonetics Corp.

Upgrade your FINVIZ experience